UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 48

Sortiert nach

Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for primary central nervous system lymphoma

Neuro-oncology (Charlottesville, Va.), 2016-03, Vol.18 (3), p.361-367

2016

Volltextzugriff (PDF)

Osteopontin in cerebrospinal fluid as diagnostic biomarker for central nervous system lymphoma

Journal of neuro-oncology, 2016-08, Vol.129 (1), p.165-171

2016

Volltextzugriff (PDF)

Treatment Strategies and Prognostic Factors in Secondary Central Nervous System Lymphoma: A Multicenter Study of 124 Patients

HemaSphere, 2023-08, Vol.7 (8), p.e926-n/a

2023

Volltextzugriff (PDF)

Effects of spring wheat / faba bean mixtures on early crop development

Plant and soil, 2023-06

2023

Volltextzugriff (PDF)

High-dose chemotherapy and autologous stem cell transplantation in primary lymphomatoid granulomatosis of the central nervous system

Journal of cancer research and clinical oncology, 2023-08, Vol.149 (9), p.5729-5732

2023

Volltextzugriff (PDF)

Root growth and belowground interactions in spring wheat /faba bean intercrops

Plant and soil, 2024-05

2024

Volltextzugriff (PDF)

Correction to: Root growth and belowground interactions in spring wheat /faba bean intercrops

Plant and soil, 2024-06

2024

Volltextzugriff (PDF)

Twenty-year follow-up of a pilot/phase II trial on the Bonn protocol for primary CNS lymphoma

Neurology, 2020-12, Vol.95 (23), p.e3138

2020

Volltextzugriff (PDF)

Complications of intracerebroventricular chemotherapy via subgaleal reservoir in primary central nervous system lymphoma: A single‐institution experience on 1247 installations in 94 consecutive patients

Hematological oncology, 2021-04, Vol.39 (2), p.176-184

2021

Volltextzugriff (PDF)

The value of bone marrow biopsy for staging of patients with primary CNS lymphoma

Neuro-oncology (Charlottesville, Va.), 2021-12, Vol.23 (12), p.2076-2084

2021

Volltextzugriff (PDF)

MGMT promoter methylation analysis for allocating combined CCNU/TMZ chemotherapy: Lessons learned from the CeTeG/NOA‐09 trial

International journal of cancer, 2021-04, Vol.148 (7), p.1695-1707

2021

Volltextzugriff (PDF)

Neurocognitive functioning and health-related quality of life in adult medulloblastoma patients: long-term outcomes of the NOA-07 study

Journal of neuro-oncology, 2020-05, Vol.148 (1), p.117-130

2020

Volltextzugriff (PDF)

BIOM-64. A PROGNOSTIC SCORING SYSTEM FOR IMMUNODEFICIENCY-ASSOCIATED PRIMARY CNS LYMPHOMAS: AN INTERNATIONAL MULTI-CENTER STUDY

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v19-v19

2023

Volltextzugriff (PDF)

ACTR-53. MGMT PROMOTER METHYLATION ANALYSIS FOR ALLOCATING COMBINED CCNU/TMZ CHEMOTHERAPY: LESSONS LEARNED FROM THE CeTeG/NOA-09 TRIAL

Neuro-oncology (Charlottesville, Va.), 2019-11, Vol.21 (Supplement_6), p.vi25-vi26

2019

Volltextzugriff (PDF)

A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FAS

The Journal of experimental medicine, 2021-02, Vol.218 (2)

2021

Volltextzugriff (PDF)

Elevated cognitive control over reward processing in recovered female patients with anorexia nervosa

Journal of psychiatry & neuroscience, 2015-09, Vol.40 (5), p.307-315

2015

Volltextzugriff (PDF)

Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial

The Lancet (British edition), 2018-09, Vol.392 (10150), p.849-856

2018

Volltextzugriff (PDF)

One in Four Questioned Children Faces Problems Regarding Reintegration Into Physical Education at School After Treatment for Pediatric Cancer

Pediatric blood & cancer, 2016-04, Vol.63 (4), p.737-739

2016

Volltextzugriff (PDF)

Genotype and phenotype in patients with Noonan syndrome and a RIT1 mutation

Genetics in medicine, 2016-12, Vol.18 (12), p.1226-1234

2016

Volltextzugriff (PDF)

Long-term neurocognitive function and quality of life after multimodal therapy in adult glioma patients: a prospective long-term follow-up

Journal of neuro-oncology, 2023-09, Vol.164 (2), p.353-366

2023

Volltextzugriff (PDF)

Motor Performance After Treatment for Pediatric Bone Tumors

Journal of pediatric hematology/oncology, 2015-10, Vol.37 (7), p.509-514

2015

Volltextzugriff (PDF)

Immunological recovery following HLA‐matched CD3+ TCR αß+/CD19+ depleted hematopoietic stem cell transplantation in children

Pediatric transplantation, 2022-08, Vol.26 (5), p.e14285-n/a

2022

Volltextzugriff (PDF)

Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort

Annals of the rheumatic diseases, 2019-05, Vol.78 (5), p.648

2019

Volltextzugriff (PDF)

Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis

Annals of the rheumatic diseases, 2019-09, Vol.78 (9), p.1242

2019

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Full Text

PublikationsformArtikel

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(43)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for primary central nervous system lymphoma

Osteopontin in cerebrospinal fluid as diagnostic biomarker for central nervous system lymphoma

Treatment Strategies and Prognostic Factors in Secondary Central Nervous System Lymphoma: A Multicenter Study of 124 Patients

Effects of spring wheat / faba bean mixtures on early crop development

High-dose chemotherapy and autologous stem cell transplantation in primary lymphomatoid granulomatosis of the central nervous system

Root growth and belowground interactions in spring wheat /faba bean intercrops

Correction to: Root growth and belowground interactions in spring wheat /faba bean intercrops

Twenty-year follow-up of a pilot/phase II trial on the Bonn protocol for primary CNS lymphoma

Complications of intracerebroventricular chemotherapy via subgaleal reservoir in primary central nervous system lymphoma: A single‐institution experience on 1247 installations in 94 consecutive patients

The value of bone marrow biopsy for staging of patients with primary CNS lymphoma

MGMT promoter methylation analysis for allocating combined CCNU/TMZ chemotherapy: Lessons learned from the CeTeG/NOA‐09 trial

Neurocognitive functioning and health-related quality of life in adult medulloblastoma patients: long-term outcomes of the NOA-07 study

BIOM-64. A PROGNOSTIC SCORING SYSTEM FOR IMMUNODEFICIENCY-ASSOCIATED PRIMARY CNS LYMPHOMAS: AN INTERNATIONAL MULTI-CENTER STUDY

ACTR-53. MGMT PROMOTER METHYLATION ANALYSIS FOR ALLOCATING COMBINED CCNU/TMZ CHEMOTHERAPY: LESSONS LEARNED FROM THE CeTeG/NOA-09 TRIAL

A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FAS

Elevated cognitive control over reward processing in recovered female patients with anorexia nervosa

Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial

One in Four Questioned Children Faces Problems Regarding Reintegration Into Physical Education at School After Treatment for Pediatric Cancer

Pontocerebellar hypoplasia type 1: clinical spectrum and relevance of EXOSC3 mutations

Genotype and phenotype in patients with Noonan syndrome and a RIT1 mutation

Long-term neurocognitive function and quality of life after multimodal therapy in adult glioma patients: a prospective long-term follow-up

Motor Performance After Treatment for Pediatric Bone Tumors

Immunological recovery following HLA‐matched CD3+ TCR αß+/CD19+ depleted hematopoietic stem cell transplantation in children

Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort

Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis

Aktive Filter

Suchergebnisse filtern